Safety and Efficacy Assessment of Red Ginseng Oil (KGC11o) in Men with Lower Urinary Tract Symptoms

Safety and Efficacy Assessment of Red Ginseng Oil (KGC11o) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-blind, Placebo-controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008453

Enrollment

100

Registered

2023-05-19

Start date

2020-04-20

Completion date

Unknown

Last updated

2023-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The clinical trial assessment group was administered two KGC11o 500 mg capsules once a day (1,000 mg per day). The placebo group received two capsules of the same appearance and

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male with a Total IPSS (international prostate symptom score) score of 8-19

Exclusion criteria

Exclusion criteria: 1) Patients undergoing treatment for malignant tumors 2) Patients with a serum PSA concentration of 4.0 ng/mL or higher 3) Patients with a maximum urinary flow rate less than 5 mL/sec or residual urine volume exceeding 150 mL 4) Patients who had undergone prostate surgery 5) Patients with uncontrolled hypertension or diabetes 6) and any other patients whose medical condition was determined to be problematic to participate in this study

Design outcomes

Primary

Measure	Time frame
The change of International prostate symtom score (IPSS) from baseline	—

Secondary

Measure	Time frame
The change of International Index of Erectile Function (IIEF) score from baseline;The change of maximum flow rate (Q max), and post-void residual volume (PVR)	—

Countries

Korea, Republic of

Contacts

Public ContactDongho Shin

Catholic Kwandong University International St.Mary's Hospital

eds8813@naver.com+82-2-2258-1403

Outcome results